OKRA Technologies is a leading artificial intelligence (AI) company that supports life sciences in bringing the right treatment to the right patient at speed.
It focuses on building and deploying AI products for life science clients, delivering AI driven insights that employees in life science companies can easily query at their desks or whilst on the move.
OKRA solutions deliver accurate predictions, suggestions and explanations (reasons) to empower life sciences executives to deliver the right drug to the right patient with humanised, validated and explainable AI outputs.
With a deep expertise in AI, in-depth medical knowledge and product knowledge, OKRA have co-created their products with the industry. In this way they have been able to transform the way life sciences tackle key industry challenges.
OKRA's AI solutions are translating large clinical, scientific and commercial data sets into actionable insights. Since launching in 2015, OKRA Founder and CEO Dr Loubna Bouarfa has been named an MIT Top Innovator Under 35 and a Forbes Europe’s Top 50 Women In Technology – in 2018 – and last year, OKRA was named the Best Female-Led Startup at the StartUp Europe Awards.
The OKRA team focuses on operationalising AI in an ethical way, putting users at the centre and empowering them with explainable AI outputs. The company mission is to get the right treatment to the right patient at the right time, by building the world’s most trustworthy artificial intelligence engine.
OKRA is working with many of the leading Pharmaceutical companies across commercial, clinical, medical and market access.